Cargando…

Angiotensin II during Experimentally Simulated Central Hypovolemia

Central hypovolemia, defined as diminished blood volume in the heart and pulmonary vascular bed, is still an unresolved problem from a therapeutic point of view. The development of pharmaceutical agents targeted at specific angiotensin II receptors, such as the non-peptidergic AT(2)-receptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Theo Walther, Olsen, Niels Vidiendal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776081/ https://www.ncbi.nlm.nih.gov/pubmed/26973842 http://dx.doi.org/10.3389/fcvm.2016.00006

Ejemplares similares

Association of gender with cardiovascular and autonomic responses to central hypovolemia
por: Shankhwar, Vishwajeet, et al.
Publicado: (2023)

Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials
por: Rong, Xi, et al.
Publicado: (2022)

Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor
por: Barhoumi, Tlili, et al.
Publicado: (2023)

Coagulation Changes during Central Hypovolemia across Seasons
por: Goswami, Nandu, et al.
Publicado: (2020)

Interlinking Antecedent Malaria and Hypertension Through Angiotensin II in India
por: Tiwari, Aparna, et al.
Publicado: (2021)

Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
por: Camargo, Rafael L., et al.
Publicado: (2022)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
por: Agostinucci, Kevin, et al.
Publicado: (2022)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Loss of Angiotensin II Type 2 Receptor Improves Blood Pressure in Elastin Insufficiency
por: Lin, Michelle, et al.
Publicado: (2021)

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension
por: Figueiredo Galvao, Hericka Bruna, et al.
Publicado: (2023)

MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity
por: Pilecki, Bartosz, et al.
Publicado: (2021)

Cardiomyocyte-specific deletion of TLR4 attenuates angiotensin II-induced hypertension and cardiac remodeling
por: Theobald, Drew, et al.
Publicado: (2023)

Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
por: Goswami, Nandu, et al.
Publicado: (2020)

α-Ketoglutarate Upregulates Collecting Duct (Pro)renin Receptor Expression, Tubular Angiotensin II Formation, and Na(+) Reabsorption During High Glucose Conditions
por: Guerrero, Aarón, et al.
Publicado: (2021)

EZH2 Dynamically Associates With Non-coding RNAs in Mouse Hearts After Acute Angiotensin II Treatment
por: Wang, Shun, et al.
Publicado: (2021)

Cardiovascular Response Patterns to Sympathetic Stimulation by Central Hypovolemia
por: Bronzwaer, Anne-Sophie G. T., et al.
Publicado: (2016)

Perfusion index as a predictor for central hypovolemia in humans
por: Lima, A, et al.
Publicado: (2011)

Detecting central hypovolemia in simulated hypovolemic shock by automated feature extraction with principal component analysis
por: van der Ster, Björn J. P., et al.
Publicado: (2018)

Central Hypovolemia Detection During Environmental Stress—A Role for Artificial Intelligence?
por: van der Ster, Björn J. P., et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

ADAMTS-5 Decreases in Aortas and Plasma From Aortic Dissection Patients and Alleviates Angiotensin II-Induced Smooth Muscle-Cell Apoptosis
por: Zeng, Tao, et al.
Publicado: (2020)

Profiling of miR-205/P4HA3 Following Angiotensin II-Induced Atrial Fibrosis: Implications for Atrial Fibrillation
por: Xiao, Zezhou, et al.
Publicado: (2021)

Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of “Vascular Memory”
por: Pothen, Lucie, et al.
Publicado: (2022)

Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism
por: Xu, Dengyue, et al.
Publicado: (2022)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
por: Huang, Linna, et al.
Publicado: (2021)

Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia
por: Bouchacourt, Juan P., et al.
Publicado: (2017)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice
por: Wei, Ming, et al.
Publicado: (2021)

Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Attenuates the Development of Angiotensin II-Mediated Abdominal Aortic Aneurysm in Obese ob/ob Mice
por: Saito, Akimichi, et al.
Publicado: (2021)

Distinct Contribution of Global and Regional Angiotensin II Type 1a Receptor Inactivation to Amelioration of Aortopathy in Tgfbr1(M318R/+) Mice
por: Bramel, Emily E., et al.
Publicado: (2022)

Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer
por: Du, Xianglin L., et al.
Publicado: (2023)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion
por: Li, Kangbo, et al.
Publicado: (2023)

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
por: Williams, Bryan, et al.
Publicado: (2014)

Sympathetic Responses to Central Hypovolemia: New Insights from Microneurographic Recordings
por: Ryan, Kathy L., et al.
Publicado: (2012)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
por: Uchikado, Yoshihiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3o6vohmcgefu6o6hc3qim1sr2v